In addition, we also focus on the impact of changes in activation or inhibition conditions of VRAC on immune response, and explore the possibility of VRAC agonists or inhibitors becoming immunotherapy adjuvants.
In addition, we also pay attention to the influence of the change of activation or inhibition conditions of VRAC on immune response, and explore the possibility of VRAC agonists or inhibitors becoming immunotherapy adjuvants.